tiprankstipranks
Trending News
More News >
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558)
:1558
Hong Kong Market
Advertisement

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558) Ratios

Compare
0 Followers

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Ratios

HK:1558's free cash flow for Q4 2024 was ¥0.67. For the 2024 fiscal year, HK:1558's free cash flow was decreased by ¥ and operating cash flow was ¥-0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.77 1.40 1.01 1.66 0.78
Quick Ratio
1.54 1.30 0.95 1.44 0.69
Cash Ratio
0.49 0.39 0.19 0.91 0.49
Solvency Ratio
2.26 0.50 0.08 -0.07 0.22
Operating Cash Flow Ratio
<0.01 0.39 0.34 -0.54 0.31
Short-Term Operating Cash Flow Coverage
0.02 0.72 0.54 -13.67 0.46
Net Current Asset Value
¥ 1.11B¥ 1.24B¥ -805.78M¥ -2.46B¥ -1.19B
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.20 0.32 0.30 0.31
Debt-to-Equity Ratio
0.26 0.33 0.65 0.55 0.62
Debt-to-Capital Ratio
0.21 0.25 0.39 0.35 0.38
Long-Term Debt-to-Capital Ratio
0.08 0.04 0.11 0.35 0.04
Financial Leverage Ratio
1.46 1.61 2.02 1.81 1.95
Debt Service Coverage Ratio
7.57 0.97 0.20 -0.98 0.25
Interest Coverage Ratio
0.00 10.35 1.15 -1.88 3.41
Debt to Market Cap
0.17 0.35 0.76 0.73 0.37
Interest Debt Per Share
2.56 3.22 4.66 3.92 2.94
Net Debt to EBITDA
0.09 0.34 4.19 -9.98 1.02
Profitability Margins
Gross Profit Margin
75.03%79.21%76.00%52.93%85.03%
EBIT Margin
17.96%37.40%8.62%-46.33%35.50%
EBITDA Margin
243.07%43.62%18.46%-22.60%40.47%
Operating Profit Margin
18.11%37.40%8.62%-50.13%35.50%
Pretax Profit Margin
15.50%33.79%1.05%-73.01%43.03%
Net Profit Margin
12.96%31.66%2.05%-64.31%35.75%
Continuous Operations Profit Margin
12.96%29.48%1.31%-64.32%35.66%
Net Income Per EBT
83.63%93.69%194.32%88.08%83.08%
EBT Per EBIT
85.58%90.34%12.22%145.64%121.20%
Return on Assets (ROA)
3.88%15.64%0.64%-5.57%8.78%
Return on Equity (ROE)
5.62%25.11%1.30%-10.12%17.16%
Return on Capital Employed (ROCE)
7.03%27.99%4.64%-4.92%15.44%
Return on Invested Capital (ROIC)
4.43%19.14%2.85%-6.39%10.84%
Return on Tangible Assets
4.30%17.67%0.76%-7.00%10.56%
Earnings Yield
4.29%26.82%1.52%-13.49%10.18%
Efficiency Ratios
Receivables Turnover
1.73 3.04 3.72 1.91 5.10
Payables Turnover
5.24 6.53 5.37 3.73 1.47
Inventory Turnover
1.44 3.20 2.85 1.54 0.93
Fixed Asset Turnover
0.94 1.68 1.06 0.28 0.83
Asset Turnover
0.30 0.49 0.31 0.09 0.25
Working Capital Turnover Ratio
1.45 7.02 8.39 -23.49 2.21
Cash Conversion Cycle
395.27 178.34 157.98 330.84 215.61
Days of Sales Outstanding
211.28 120.18 98.03 191.35 71.58
Days of Inventory Outstanding
253.58 114.07 127.92 237.37 392.74
Days of Payables Outstanding
69.60 55.92 67.97 97.87 248.72
Operating Cycle
464.87 234.26 225.95 428.71 464.33
Cash Flow Ratios
Operating Cash Flow Per Share
0.03 1.90 1.93 -0.76 1.18
Free Cash Flow Per Share
-0.43 1.22 1.28 -1.16 0.28
CapEx Per Share
0.46 0.67 0.65 0.41 0.90
Free Cash Flow to Operating Cash Flow
-15.47 0.64 0.66 1.54 0.23
Dividend Paid and CapEx Coverage Ratio
0.06 2.81 2.98 -1.86 1.07
Capital Expenditure Coverage Ratio
0.06 2.81 2.98 -1.86 1.31
Operating Cash Flow Coverage Ratio
0.01 0.64 0.44 -0.21 0.43
Operating Cash Flow to Sales Ratio
<0.01 0.27 0.45 -0.73 0.55
Free Cash Flow Yield
-3.31%14.51%22.37%-23.38%3.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.34 3.73 65.93 -7.41 9.82
Price-to-Sales (P/S) Ratio
3.07 1.18 1.35 4.77 3.51
Price-to-Book (P/B) Ratio
1.32 0.94 0.86 0.75 1.69
Price-to-Free Cash Flow (P/FCF) Ratio
-30.26 6.89 4.47 -4.28 26.99
Price-to-Operating Cash Flow Ratio
461.58 4.44 2.97 -6.58 6.34
Price-to-Earnings Growth (PEG) Ratio
-0.33 <0.01 -0.58 0.04 -0.18
Price-to-Fair Value
1.32 0.94 0.86 0.75 1.69
Enterprise Value Multiple
1.35 3.05 11.50 -31.08 9.69
Enterprise Value
12.25B 8.36B 7.95B 6.42B 9.21B
EV to EBITDA
1.35 3.05 11.50 -31.08 9.69
EV to Sales
3.29 1.33 2.12 7.03 3.92
EV to Free Cash Flow
-32.46 7.76 7.04 -6.30 30.16
EV to Operating Cash Flow
502.05 5.00 4.68 -9.69 7.09
Tangible Book Value Per Share
8.36 7.33 4.87 4.42 3.16
Shareholders’ Equity Per Share
9.75 9.00 6.69 6.62 4.42
Tax and Other Ratios
Effective Tax Rate
0.28 0.13 0.25 -0.12 0.17
Revenue Per Share
4.27 7.14 4.26 1.04 2.12
Net Income Per Share
0.55 2.26 0.09 -0.67 0.76
Tax Burden
0.84 0.94 1.94 0.88 0.83
Interest Burden
0.86 0.90 0.12 1.58 1.21
Research & Development to Revenue
0.13 0.03 0.03 0.15 0.05
SG&A to Revenue
0.10 0.06 0.09 0.39 0.14
Stock-Based Compensation to Revenue
0.02 <0.01 0.00 0.00 0.00
Income Quality
0.05 0.79 22.19 1.13 1.55
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis